Providing affordable medicines that adhere to international standards and having direct access to the research and development portfolio of its mother company are just two of the aces this generics company in Holzkirchen, Germany has up its sleeve. During a tour to one of its several global production plants in Kundl, Austria—the home of oral penicillin—Inquirer Science and Health was able to sit down with executives of the international generics firm Sandoz International GmbH. There, they explained that mother company Novartis was its big advantage over other generics firms.
